Forward chemical genetic approach identifies new role for GAPDH in insulin signaling

Nature Chemical Biology

Volumn 3, Issue 1, 2007, Pages 55-59

  Min, Jaeki ^a   Kyung Kim, Yun ^a   Cipriani, Patricia G ^a   Kang, Mira ^a   Khersonsky, Sonya M ^a   Walsh, Daniel P ^a   Lee, Ji Young ^a   Niessen, Sherry ^b   Yates III, John R ^b   Gunsalus, Kristin ^a   Piano, Fabio ^a   Chang, Young Tae ^a  

^a NEW YORK UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAF 2 PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INSULIN; PHOSPHATASE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL GENETICS; CONTROLLED STUDY; GENE; GENE LIBRARY; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CAENORHABDITIS ELEGANS; MAMMALIA;

EID: 33845789522     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio833     Document Type: Article

References (27)

1. Taylor, S.I. et al. Mutations in the insulin receptor gene. Endocr. Rev. 13, 566-595 (1992).
2. Hanover, J.A. et al. A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. Proc. Natl. Acad. Sci. USA 102, 11266-11271 (2005).
3. Khersonsky, S.M. et al. Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 125, 11804-11805 (2003).
4. Williams, D. et al. Identification of compounds that bind mitochondrial F1F0 ATPase by screening a triazine library for correction of albinism. Chem. Biol. 11, 1251-1259 (2004).
5. Uttamchandani, M. et al. Microarrays of tagged combinatorial triazine libraries in the discovery of small-molecule ligands of human IgG. J. Comb. Chem. 6, 862-868 (2004).
6. Carroll, P.M., Dougherty, B., Ross-Macdonald, P., Browman, K. & FitzGerald, K. Model systems in drug discovery: chemical genetics meets genomics. Pharmacol. Ther. 99, 183-220 (2003).
7. Choy, R.K. & Thomas, J.H. Fluoxetine-resistant mutants in C. elegans define a novel family of transmembrane proteins. Mol. Cell 4, 143-152 (1999).
8. Gems, D. et al. Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics 150, 129-155 (1998).
9. Kimura, K.D., Tissenbaum, H.A., Liu, Y.X. & Ruvkun, G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277, 942-946 (1997).
10. Ashrafi, K. et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421, 268-272 (2003).
11. Nagashima, H. & Matsumura, F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced down-regulation of glucose transporting activities in mouse 3T3-L1 preadipocyte. J. Environ. Sci. Health B 37, 1-14 (2002).
12. Itoh, Y., Abe, T., Takaoka, R. & Tanahashi, N. Fluorometric determination of glucose utilization in neurons in vitro and in vivo. J. Cereb. Blood Flow Metab. 24, 993-1003 (2004).
13. Cheeseman, I.M. et al. Implication of a novel multiprotein Dam1p complex in outer kinetochore function. J. Cell Biol. 155, 1137-1145 (2001).
14. Sirover, M.A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim. Biophys. Acta 1432, 159-184 (1999).
15. Hayes, J.P. & Tipton, K.F. Interactions of the neurotoxin 6-hydroxydopamine with glyceraldehyde-3-phosphate dehydrogenase. Toxicol. Lett. 128, 197-206 (2002).
16. Bitan, G., Lomakin, A. & Teplow, D.B. Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276, 35176-35184 (2001).
17. Carlile, G.W. et al. Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol. Pharmacol. 57, 2-12 (2000).
18. Grigorieva, J.A., Dainiak, M.B., Katrukha, A.G. & Muronetz, V.I. Antibodies to the nonnative forms of D-glyceraldehyde-3-phosphate dehydrogenase: identification, purification, and influence on the renaturation of the enzyme. Arch. Biochem. Biophys. 369, 252-260 (1999).
19. Constantinides, S.M. & Deal, W.C., Jr. Reversible dissociation of tetrameric rabbit muscle glyceraldehyde 3-phosphate dehydrogenase into dimers or monomers by adenosine triphosphate. J. Biol. Chem. 244, 5695-5702 (1969).
20. Pagliarini, D.J., Worby, C.A. & Dixon, J.E. A PTEN-like phosphatase with a novel substrate specificity. J. Biol. Chem. 279, 38590-38596 (2004).
21. Taylor, G.S. & Dixon, J.E. An assay for phosphoinositide phosphatases utilizing fluorescent substrates. Anal. Biochem. 295, 122-126 (2001).
22. Chen, G. et al. Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin. J. Biol. Chem. 279, 39705-39709 (2004).
23. Strawbridge, A.B. & Elmendorf, J.S. Phosphatidylinositol 4,5-bisphosphate reverses endothelin-1-induced insulin resistance via an actin-dependent mechanism. Diabetes 54, 1698-1705 (2005).
24. Glaser, P.E., Han, X. & Gross, R.W. Tubulin is the endogenous inhibitor of the glyceraldehyde 3-phosphate dehydrogenase isoform that catalyzes membrane fusion: implications for the coordinated regulation of glycolysis and membrane fusion. Proc. Natl. Acad. Sci. USA 99, 14104-14109 (2002).
25. 2+ release via locally derived NADH. Proc. Natl. Acad. Sci. USA 102, 1357-1359 (2005).
26. Niswender, K.D. et al. Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J. Histochem. Cytochem. 51, 275-283 (2003).
27. Taylor, G.S. & Dixon, J.E. PTEN and myotubularins: families of phosphoinositide phosphatases. Methods Enzymol. 366, 43-56 (2003).